Alejandro R. Rodriguez, MD, presented “Care Considerations for the Man on ADT” at the 11th Urology Today conference on October 27, 2023.

This content is available free to the GRU Community. Login or create an account to view it.

Login

Create an Account

How to cite: Rodriguez, Alejandro R. Care Considerations for the Man on ADT.” October 2023. Accessed Jul 2024. https://grandroundsinurology.com/care-considerations-for-the-man-on-adt/

Care Considerations for the Man on ADT – Summary

Alejandro R. Rodriguez, MD, discusses the management of metabolic, cardiovascular, and other side effects of Androgen Deprivation Therapy (ADT). In this lecture, Dr. Rodriguez highlights common side effects of ADT as a treatment, including:

  • Bone-Density Loss
  • Cardiovascular Disease
  • Diabetes and Other Metabolism Changes
  • Sexual Dysfunction

For each of these conditions, Dr. Rodriguez presents management strategies that can be used by physicians, patients, and members of the patients’ care team.

About The 11th Urology Today Conference:

Presented by chair Ryan P. Terlecki, MD, FACS, the 11th Urology Today conference was designed to keep urologists, urologic oncologists, and other healthcare providers educated on the most pertinent issues in urology practices. Areas of focus included urologic oncology, men’s health and reconstruction, female urology, pediatric urology, kidney stones and related conditions, and methods of providing the best care amidst the required logistics of the business side of medicine.

For further educational activities from this conference, visit our collection page.

ABOUT THE AUTHOR

Dr. Rodriguez is a urologist with subspecialty in Urology Oncology, as well as, robotics and minimally invasive surgery. He is American Board of Urology (ABU) certified and currently hold the rank of Associate Professor and the title of Director of Minimally Invasive Surgery for the Urology Department at Wake Forest.

He performs robotic assisted surgery for the treatment of prostate cancer, kidney cancer and bladder cancer, as well as any other malignant and benign diseases of the genitourinary system and have published over 200 peer reviewed manuscripts and abstracts regarding these areas of interest.

He is Fellowship trained from Urology Oncology at Moffitt Cancer Center and Research Institute in Tampa, Florida, and Fellowship trained in Urology Oncology and Minimally Invasive Surgery at the Centre Hospitalier Universitaire de Rennes in France.

He completed my residency training and chief residency in the department of urology of the University of South Florida Morsani College of Medicine in Tampa, Florida.

He is the present Secretary General of the Confederacion Americana de Urologia (CAU) and the editor of the American Urological Association (AUA) News in Spanish.

He is an honorary member of multiple societies world-wide and enjoys teaching and participating in continuous medical education for medical students, residents, urology colleagues, and the community we serve.